Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/18010| Title: | Analysis of a Novel pncA Mutation for Susceptibility to Pyrazinamide Therapy. | Austin Authors: | Karmakar, Malancha;Globan, Maria;Fyfe, Janet A M;Stinear, Timothy P;Johnson, Paul D R ;Holmes, Natasha E ;Denholm, Justin T;Ascher, David B | Affiliation: | University of Melbourne Bio21 Molecular Science and Biotechnology Institute, Department of Biochemistry and Molecular Biology, Parkville, Victoria, Australia University of Melbourne, Victorian Tuberculosis Program, Melbourne Health, Melbourne, Victoria, Australia Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology , Melbourne, Victoria, Australia Victorian Infectious Diseases Reference Laboratory (VIDRL), Mycobacterium Reference Laboratory, Melbourne, Victoria, Australia World Health Organization Collaborating Centre for Mycobacterium ulcerans, Melbourne, Victoria, Australia Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia Victorian Infectious Diseases Service and Department of Microbiology and Immunology, at the Peter Doherty Institute for Infection and Immunity,, Parkville, Australia University of Cambridge, Department of Biochemistry, Cambridge, Cambridgeshire, United Kingdom of Great Britain and Northern Ireland |
Issue Date: | 25-Apr-2018 | metadata.dc.date: | 2018-04-25 | Publication information: | American Journal of Respiratory and Critical Care Medicine 2018; 198(4): 541-544 | URI: | http://ahro.austin.org.au/austinjspui/handle/1/18010 | DOI: | 10.1164/rccm.201712-2572LE | ORCID: | 0000-0003-2948-2413 | PubMed URL: | 29694240 | Type: | Journal Article | Subjects: | Pyrazinamide resistance Structural bioinformatics Tuberculosis treatment pncA mutations |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.